211 related articles for article (PubMed ID: 37546745)
1. YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.
Xio Y; Zhou L; Andl T; Zhang Y
Res Sq; 2023 Jul; ():. PubMed ID: 37546745
[TBL] [Abstract][Full Text] [Related]
2. YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.
Xiao Y; Zhou L; Andl T; Zhang Y
Oncogene; 2024 Mar; 43(12):884-898. PubMed ID: 38308096
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness.
Angelucci C; Maulucci G; Lama G; Proietti G; Colabianchi A; Papi M; Maiorana A; De Spirito M; Micera A; Balzamino OB; Di Leone A; Masetti R; Sica G
PLoS One; 2012; 7(12):e50804. PubMed ID: 23251387
[TBL] [Abstract][Full Text] [Related]
4. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
[TBL] [Abstract][Full Text] [Related]
5. YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts.
Shen T; Li Y; Wang D; Su Y; Li G; Shang Z; Niu Y; Tan X
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166540. PubMed ID: 36100154
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
Ping Q; Wang C; Cheng X; Zhong Y; Yan R; Yang M; Shi Y; Li X; Li X; Huang W; Wang L; Bi X; Hu L; Yang Y; Wang Y; Gong R; Tan J; Li R; Li H; Li J; Wang W; Li R
J Transl Med; 2023 Jul; 21(1):475. PubMed ID: 37461061
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
[TBL] [Abstract][Full Text] [Related]
9. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation.
Izar B; Joyce CE; Goff S; Cho NL; Shah PM; Sharma G; Li J; Ibrahim N; Gold J; Hodi FS; Garraway LA; Novina CD; Bertagnolli MM; Yoon CH
Pigment Cell Melanoma Res; 2016 Nov; 29(6):656-668. PubMed ID: 27482935
[TBL] [Abstract][Full Text] [Related]
13. BRAF Inhibitors Reprogram Cancer-Associated Fibroblasts to Drive Matrix Remodeling and Therapeutic Escape in Melanoma.
Liu T; Zhou L; Xiao Y; Andl T; Zhang Y
Cancer Res; 2022 Feb; 82(3):419-432. PubMed ID: 35064015
[TBL] [Abstract][Full Text] [Related]
14. Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.
Zhou L; Yang K; Andl T; Wickett RR; Zhang Y
J Cancer; 2015; 6(8):717-26. PubMed ID: 26185533
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
Lu C; Zhang C
Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606
[TBL] [Abstract][Full Text] [Related]
16. Suppression of MAPK signaling in BRAF-activated PTEN-deficient melanoma by blocking β-catenin signaling in cancer-associated fibroblasts.
Zhou L; Yang K; Dunaway S; Abdel-Malek Z; Andl T; Kadekaro AL; Zhang Y
Pigment Cell Melanoma Res; 2018 Mar; 31(2):297-307. PubMed ID: 29045061
[TBL] [Abstract][Full Text] [Related]
17. Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis.
Mo Y; Leung LL; Mak CSL; Wang X; Chan WS; Hui LMN; Tang HWM; Siu MKY; Sharma R; Xu D; Tsui SKW; Ngan HYS; Yung MMH; Chan KKL; Chan DW
Mol Cancer; 2023 Jan; 22(1):4. PubMed ID: 36624516
[TBL] [Abstract][Full Text] [Related]
18. Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.
Murtas D; Maxia C; Diana A; Pilloni L; Corda C; Minerba L; Tomei S; Piras F; Ferreli C; Perra MT
Histochem Cell Biol; 2017 Dec; 148(6):639-649. PubMed ID: 28828681
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone Reduces Epithelial-Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs).
Es HA; Cox TR; Sarafraz-Yazdi E; Thiery JP; Warkiani ME
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680267
[TBL] [Abstract][Full Text] [Related]
20. ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT.
Yao P; Li Y; Shen W; Xu X; Zhu W; Yang X; Cao J; Xing C
Am J Cancer Res; 2018; 8(11):2311-2324. PubMed ID: 30555746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
